About Index Trending news
Lists
Pricing
Invenra

Invenra

Invenra

Invenra is focused on developing the next generation of bestinclass biologics, with an emphasis on multispecific antibodies and their derivatives.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Venture capital
$2,930,060
Venture capital
$2,000,000
Employees

Team size

10+
Locations
HQ
$2,930,060 Venture capital
Xconomy

Invenra, Developer of Therapeutic Antibodies, Raises $2.9M

Health Funding
Xconomy

Invenra Signs On With Merck in Antibody Discovery Partnership

Health Apps & Services
Xconomy

Invenra Adds Partners, Still Open to Developing Own Drugs in Future

Science Health
$3,000,000 Venture capital
Xconomy

Invenra Raises $3M to Develop Antibodies with, and for, Drug Makers

Funding
$2,000,000 Venture capital
SmartBrief

Financing round brings in $2M for Invenra

$2,000,000 Venture capital
Xconomy

Invenra Snags $2M, Expects to Raise $1M More in Next Month

Funding Health
Xconomy

Invenra Partners With U.K. Company to Research Therapeutic Antibodies

Health Science Apps & Services